Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
Kurth KH, Bouffioux C, Sylvester R, de Pauw M. Kurth KH, et al. Among authors: bouffioux c. Prog Clin Biol Res. 1988;269:525-37. Prog Clin Biol Res. 1988. PMID: 3134663 Clinical Trial. No abstract available.
Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. European Organization for Research and Treatment of Cancer Genitourinary Group.
Bouffioux C, Kurth KH, Bono A, Oosterlinck W, Kruger CB, De Pauw M, Sylvester R. Bouffioux C, et al. J Urol. 1995 Mar;153(3 Pt 2):934-41. J Urol. 1995. PMID: 7853578 Clinical Trial.
Prognostic factors in superficial bladder cancer.
Aso Y, Anderson L, Soloway M, Bouffioux C, Chisholm G, Debruyne F, Kawai T, Kurth KH, Maru A, Straffon WG. Aso Y, et al. Among authors: bouffioux c. Prog Clin Biol Res. 1986;221:257-69. Prog Clin Biol Res. 1986. PMID: 3809183 No abstract available.
Adjuvant chemotherapy of recurrent superficial transitional cell carcinoma: results of a European organization for research on treatment of cancer randomized trial comparing intravesical instillation of thiotepa, doxorubicin and cisplatin. The European Organization for Research on Treatment of Cancer Genitourinary Group.
Bouffioux C, Denis L, Oosterlinck W, Viggiano G, Vergison B, Keuppens F, De Pauw M, Sylvester R, Cheuvart B. Bouffioux C, et al. J Urol. 1992 Aug;148(2 Pt 1):297-301. doi: 10.1016/s0022-5347(17)36577-1. J Urol. 1992. PMID: 1635122 Clinical Trial.
Phase II trials in Ta, T1 bladder cancer. The marker tumour concept.
van der Meijden AP, Hall RR, Kurth KH, Bouffioux C, Sylvester R. van der Meijden AP, et al. Among authors: bouffioux c. Br J Urol. 1996 May;77(5):634-7. doi: 10.1046/j.1464-410x.1996.09002.x. Br J Urol. 1996. PMID: 8689102 Review. No abstract available.
105 results